BEAM
Beam Therapeutics Inc.
NASDAQ · Healthcare · Biotechnology · US
$29.66
+0.68%0
Insider buys (3m)
8
Insider sells (3m)
-$12.2M
Net value (3m)
+1.1%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Jul 29, 2026 | Simon Amy · officer: Chief Medical Officer | Sale | 16,667 | $26 |
| Jul 2, 2026 | Simon Amy · officer: Chief Medical Officer | Sale | 373 | $35 |
| Jul 1, 2026 | Evans John M. · director, officer: CEO | M-Exempt | 18,663 | $0.67 |
| Jul 1, 2026 | Evans John M. · director, officer: CEO | Sale | 23,100 | $34 |
| Jul 1, 2026 | Evans John M. · director, officer: CEO | Sale | 13,421 | $35 |
| Jul 1, 2026 | Evans John M. · director, officer: CEO | M-Exempt | 25,000 | $1.03 |
| Jul 1, 2026 | Evans John M. · director, officer: CEO | Sale | 11,579 | $36 |
| Jul 1, 2026 | Evans John M. · director, officer: CEO | M-Exempt | 6,337 | $1.03 |
| Jul 1, 2026 | Evans John M. · director, officer: CEO | Sale | 1,900 | $35 |
| Jun 29, 2026 | FMR LLC · 10 percent owner, other: See Remark 1 | Sale | 251,488 | $35 |
| Jun 29, 2026 | FMR LLC · 10 percent owner, other: See Remark 1 | Sale | 33,372 | $35 |
| Jun 22, 2026 | Ciaramella Giuseppe · officer: President | M-Exempt | 6,505 | $0.67 |
| Jun 22, 2026 | Ciaramella Giuseppe · officer: President | M-Exempt | 29,000 | $1.03 |
| Jun 5, 2026 | MARAGANORE JOHN · director | A-Award | 19,676 | $30 |
| Jun 5, 2026 | Walsh Kathleen E · director | A-Award | 19,676 | $30 |
| Jun 5, 2026 | Fishman Mark · director | A-Award | 19,676 | $30 |
| Jun 5, 2026 | Shaw Christi · director | A-Award | 19,676 | $30 |
| Jun 5, 2026 | Guindo Chirfi · director | A-Award | 19,676 | $30 |
| Jun 5, 2026 | COOPER GRAHAM K · director | A-Award | 19,676 | $30 |
| Apr 6, 2026 | Cavanagh Bethany J · officer: SVP, Finance and Treasurer | Sale | 3,242 | $25 |
| Apr 6, 2026 | Bellon Christine · officer: Chief Legal Officer | Sale | 5,956 | $25 |
| Apr 6, 2026 | Simon Amy · officer: Chief Medical Officer | Sale | 6,700 | $25 |
| Apr 6, 2026 | Ciaramella Giuseppe · officer: President | Sale | 11,810 | $25 |
| Apr 6, 2026 | Evans John M. · director, officer: CEO | Sale | 30,078 | $25 |
| Apr 2, 2026 | Bellon Christine · officer: Chief Legal Officer | A-Award | 20,000 | $0.00 |
| Apr 2, 2026 | Simon Amy · officer: Chief Medical Officer | A-Award | 31,750 | $0.00 |
| Apr 2, 2026 | Ciaramella Giuseppe · officer: President | A-Award | 40,000 | $0.00 |
| Apr 2, 2026 | Cavanagh Bethany J · officer: SVP, Finance and Treasurer | A-Award | 20,000 | $0.00 |
| Apr 2, 2026 | Emany Sravan Kumar · officer: Chief Financial Officer | A-Award | 31,750 | $0.00 |
| Apr 1, 2026 | Evans John M. · director, officer: CEO | M-Exempt | 25,000 | $0.67 |
Institutional positioning
13F filings over the trailing two quarters
New 116Increased 182Reduced 145Sold out 36
| Filer | Action | Shares | Filed |
|---|---|---|---|
| FMR LLC | Increased | 12,609,002 | Aug 13, 2026 |
| FMR LLC | Increased | 12,452,199 | May 15, 2026 |
| ARK INVESTMENT MANAGEMENT LLC | Reduced | 12,133,433 | May 12, 2026 |
| FARALLON CAPITAL MANAGEMENT LLC | Increased | 10,236,396 | Aug 14, 2026 |
| ARK Investment Management LLC | Reduced | 10,234,862 | Aug 14, 2026 |
| FARALLON CAPITAL MANAGEMENT LLC | Increased | 10,134,696 | May 15, 2026 |
| BlackRock, Inc. | Increased | 8,997,542 | Aug 7, 2026 |
| BLACKROCK, INC. | Increased | 8,487,569 | May 13, 2026 |
| STATE STREET CORP | Increased | 5,827,122 | Aug 7, 2026 |
| STATE STREET CORP | Increased | 5,699,265 | May 15, 2026 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | Increased | 4,921,259 | Aug 13, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | Increased | 4,599,437 | Aug 13, 2026 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | New Position | 4,570,797 | May 8, 2026 |
| ARCH Venture Management, LLC | Unchanged | 4,540,132 | Aug 14, 2026 |
| ARCH VENTURE MANAGEMENT, LLC | Unchanged | 4,540,132 | May 15, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Jul 29, 2026